Stada ends Hedrin licensing deal with Sanofi

19 January 2018 - Deborah Wilkes


Stada Arzneimittel has regained rights to its Hedrin head-lice remedy in Belgium, Portugal and Spain, following the early termination of a licensing agreement with Sanofi.

Click tags below for more information on topics:

Sanofi Consumer Healthcare Stada

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: